Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03666988
Title First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

urethra transitional cell carcinoma

pancreatic adenocarcinoma

Advanced Solid Tumor

relapsed/refractory diffuse large B-cell lymphoma

lung non-small cell carcinoma

Therapies

GSK3368715

Age Groups: senior | adult
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
GSK Investigational Site Los Angeles California 90033 United States Details
GSK Investigational Site Newport Beach California 92663 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19104-4206 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
GSK Investigational Site Salt Lake City Utah 84112 United States Details
GSK Investigational Site Melbourne Victoria 3000 Australia Details
GSK Investigational Site Toronto Ontario M5G 1X5 Canada Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field